Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
The realm of bioprinting has witnessed a momentous development thanks to a team of innovative researchers at Penn State University. This scientific group has pioneered an advanced bioprinting technique that employs spheroids—clusters of cells—to fabricate complex tissue with enhanced precision and s
Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Imagine the potential to unlock the secrets of how our bodies maintain health and prevent disease by understanding how stem cells perceive and adapt to their environment. This quest has driven researchers from The Hospital for Sick Children (SickKids) and Institut Curie to conduct an extensive
Triple-negative breast cancer (TNBC) is a particularly aggressive form of breast cancer, accounting for 15-20% of all breast cancer cases. Known for its poor prognosis and lack of effective treatment options, TNBC presents a significant challenge in oncology. However, recent advancements in spatial
The challenge of maintaining long-term medication adherence in patients with chronic cardiovascular conditions is a significant concern in healthcare, given the impact on patient outcomes and healthcare costs. Researchers at CU Anschutz Medical Campus have embarked on an ambitious study, published
